Nongenomic activation of the GC-A enzyme by resveratrol and estradiol downstream from membrane estrogen receptors in human coronary arterial cells

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 7, 2007, Pages 508-516

  El Mowafy, A M ^a   Alkhalaf, M ^b   Jaffal, S M ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

cGMP; Estradiol; Human coronary artery; Kinase G; Membrane estrogen receptor; Nitric oxide synthase; Particulate guanylate cyclase; Resveratrol

Indexed keywords

CYCLIC GMP; ENZYME INHIBITOR; ESTRADIOL; ESTROGEN RECEPTOR; GUANYLATE CYCLASE; RESVERATROL; STILBENE DERIVATIVE;

ARTICLE; CELL CULTURE; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; VASCULAR SMOOTH MUSCLE;

CELLS, CULTURED; CORONARY VESSELS; CYCLIC GMP; ENZYME INHIBITORS; ESTRADIOL; GUANYLATE CYCLASE; HUMANS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ESTROGEN; STILBENES;

VITACEAE;

EID: 34547443390     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.04.008     Document Type: Article

References (41)

1. Fremont L. Biological effects of resveratrol. Life Sci 66 8 (January 14, 2000) 663-673
2. El-Mowafy A.M., and White R.E. Resveratrol inhibits MAPK activity nuclear translocation in coronary artery smooth muscle reversal of Endothelin-1 stimulatory effects. FEBS Lett 451 1 (1999) 63-67
3. Kopp P. Resveratrol a phytoestrogen found in red wine A possible explanation for the conundrum of the 'French paradox'?. Eur J Endocrinol 138 6 (1998) 619-620
4. El-Mowafy A.M., and Alkhalaf M. Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel estrogen receptor-independent cytostatic mechanism. Carcinogenesis 24 5 (2003) 869-873
5. Gentilli M., Mazoit J.X., Bouaziz H., Fletcher D., Casper R.F., Benhamou D., et al. Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Sci 68 11 (2001) 1317-1321
6. Basly J.P., Marre-Fournier F., LeBail J.C., Habrioux G., and Chulia A.J. Estrogenic/antiestrogenic scavenging properties of (E)-(Z)-resveratrol. Life Sci 66 9 (2000) 769-777
7. de Lorgeril M., Salen P., Guiraud A., Boucher F., and de Leiris J. Resveratrol and non-ethanolic components of wine in experimental cardiology. Nutr Metab Cardiovasc Dis 13 2 (2003) 100-103
8. Soleas G.J., Diam E.P., and Goldberg D.M. Wine as a biological fluid history production role in disease prevention. J Clin Lab Anal 11 5 (1997) 287-313
9. Chen C.K., and Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 27 2 (1996) 363-366
10. Naderali E.K., Smith S.L., Doyle P.J., and Williams G. The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean obese rats. Clin Sci (Lond) 100 1 (2001) 55-60
11. Jager U., and Nguoyen-Doung. Relaxant effects of trans-resveratrol on isolated porcine coronary arteries. Drug Res 49 1 (1999) 207-211
12. Chen Z.J., Che D., and Chang C.H. Antioxidants, vitamin C and dithiothreitol activate membrane-bound guanylate cyclase in PC12 cells. J Pharm Pharmacol 53 2 (2001) 243-247
13. Chen Z.J., Vetter M., Chang G.D., Liu S., and Chang C.H. Quercetin a phytoestrogen dietary flavonoid activates different membrane-bound guanylate cyclase isoforms in LLC-PK1 PC12 cells. J Pharm Pharmacol 55 3 (2003) 353-358
14. Pelligrino D.A., and Wang Q. Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol 56 1 (1998) 1-18
15. Abou-Zeid L.A., and El-Mowafy A.M. Differential recognition of resveratrol isomers by human estrogen receptor-α: a molecular dynamics evaluation of stereoselective ligand binding. Chirality 16 3 (2004) 190-195
16. A receptors activate adenylyl cyclase in rat trachea Molecular mechanisms Physiological implications. Life Sci 61 15 (1997) 1529-1538
17. 2-dependent mechanism: a novel counterregulatory mechanism of ET-Induced contraction in airway smooth muscle. Biochem Biophys Res Commun 286 2 (2001) 388-393
18. White R.E., Kryman J., El-Mowafy A.M., Han G., and Carrier G.O. cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BKCa channel activity in coronary artery smooth muscle cells. Circ Res 86 (2000) 897-905
19. Potter L.R., and Hunter T. Activation of protein kinase C stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue a possible mechanism of heterologous desensitization. J Biol Chem 275 40 (2000) 31099-31106
20. Pervaiz S. Resveratrol: from grapevines to mammalian biology Effect of dietary patterns on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH), Trial DASH Collaborative Research Group. FASEB J 17 14 (2003) 1975-1985
21. Moore T.J., Vollmer W.M., Appel L.J., Sacks F.M., Svetkey L.P., Vogt T.M., et al. Effect of dietary patterns on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension 34 3 (1999) 472-477
22. Wu J.M., Wang Z.R., Hsieh T.C., Bruder J.L., Zou J.G., and Huang Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 8 1 (2001) 3-17
23. Zou J., Huang Y., Chen Q., Wang N., Cao K., Hsieh T.C., et al. Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells. Intl J Oncol 15 4 (1999) 647-651
24. Lucas K.A., Pitari G.M., Kazerounian S., et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52 3 (2000) 375-414
25. Soderling S.H., and Beavo J.A. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 12 2 (2000) 174-179
26. Lee J., Kang D.G., Kook H., Kim I.K., and Oh B.K. Differentially-altered vascular guanylate cyclase isoforms in experimental hypertensive rats. J Korean Med Sci 14 (1999) 386-392
27. Arjona A.A., Hsu C.A., Wrenn D.S., and Hill N.S. Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds. Gen Pharmacol 28 3 (1997) 387-392
28. Mizutani K., Ikeda K., Kawai Y., and Yamori Y. Extract of wine phenolics improves aortic biomechanical properties in stroke-prone spontaneously hypertensive rats (SHRSP). J Nutr Sci Vitaminol 45 1 (1999) 95-106
29. Hamad A.M., and Knox A.J. Mechanisms involved in desensitization of particulate guanylyl cyclase in human airway smooth muscle the role of protein kinase C. Biochem Biophys Res Commun 266 1 (1999) 152-155
30. Alfonzo M.J., de Becemberg I.L., de Villaroel S.S., de Herrera V.N., Misle A.J., and de Alfonzo R.G. Two opposite signal transducing mechanisms regulate a G-protein-coupled guanylyl cyclase. Arch Biochem Biophys 1350 1 (1998) 19-25
31. Mizutani K., Ikeda K., and Yamori Y. Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Biochem Biophys Res Commun 274 1 (2000) 61-67
32. Chen Z.-J., Vetter M., Geen-Dong Chang G., Liu S., Ding Y., and Chang C.-H. Non-genomic effects of tamoxifen on the activation of membrane-bound guanylate cyclase GC-A. J Pharm Pharmacol 55 11 (2003) 1539-1545
33. El-Mowafy A.M., Abou-Zeid L.A., and Edafiogho I. Recognition of Resveratrol by the human estrogen receptor-α: a molecular modeling approach to understand its biological actions. Med Princ Pract 11 (2002) 86-92
34. Kelley M.J., and Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12 (2001) 152-156
35. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., and Shaul P.W. Estrogen receptor-mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103 (1999) 401-406
36. Watters J.J., Campbell J.S., Cunningham M.J., Krebs E.G., and Dorsa D.M. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein tyrosine kinase signaling cascade and c-fos immediate early gene transcription. Endocrinology 138 (1997) 4030-4033
37. Filardo E.J., Quinn J.A., Bland K.I., and Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14 (2000) 1649-1660
38. Goldberg D.M., Yan J., and Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36 1 (2003) 79-87
39. Bertelli A., Bertelli A.A., Gozzini A., and Giovannini L. Plasma tissue resveratrol concentrations pharmacological activity. Drugs Exp Clin Res 24 3 (1998) 133-138
40. Corder R., Crozier A., and Kroon P.A. Drinking your health? It's too early to say. Nature 426 6963 (2003) 119
41. Savouret J.F., Berdeaux A., and Casper R.F. The aryl hydrocarbon receptor and its xenobiotic ligands: a fundamental trigger for cardiovascular diseases. Nutr Metab Cardiovasc Dis 13 2 (2003) 104-113